These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. 2001 assessment of nutritional influences on risk for cataract. Taylor A; Hobbs M Nutrition; 2001 Oct; 17(10):845-57. PubMed ID: 11684392 [TBL] [Abstract][Full Text] [Related]
28. Cataract prevention: time for a clinical trial? Robertson JM Br J Clin Pract; 1990 Nov; 44(11):475-6. PubMed ID: 2282300 [No Abstract] [Full Text] [Related]
29. Eating for better vision and healthy eyes. Hagberg L Diabetes Self Manag; 2002; 19(5):8, 10, 12-3. PubMed ID: 12561751 [No Abstract] [Full Text] [Related]
30. Lipofuscin and macular degeneration. Wolf G Nutr Rev; 2003 Oct; 61(10):342-6. PubMed ID: 14604266 [TBL] [Abstract][Full Text] [Related]
31. Scientific basis for medical therapy of cataracts by antioxidants. Varma SD Am J Clin Nutr; 1991 Jan; 53(1 Suppl):335S-345S. PubMed ID: 1985407 [TBL] [Abstract][Full Text] [Related]
32. The 2001 assessment of nutritional influences on risk of cataract. Taylor A; Hobbs M Nestle Nutr Workshop Ser Clin Perform Programme; 2002; 6():163-89; discussion 189-91. PubMed ID: 16969974 [No Abstract] [Full Text] [Related]
33. Vitamin E intake and risk of cataracts in humans. Robertson JM; Donner AP; Trevithick JR Ann N Y Acad Sci; 1989; 570():372-82. PubMed ID: 2629606 [TBL] [Abstract][Full Text] [Related]
34. Prospective cohort study of antioxidant vitamin supplement use and the risk of age-related maculopathy. Christen WG; Ajani UA; Glynn RJ; Manson JE; Schaumberg DA; Chew EC; Buring JE; Hennekens CH Am J Epidemiol; 1999 Mar; 149(5):476-84. PubMed ID: 10067908 [TBL] [Abstract][Full Text] [Related]
35. AREDS misses on safety. Gaynes BI Arch Ophthalmol; 2003 Mar; 121(3):416-7. PubMed ID: 12617719 [No Abstract] [Full Text] [Related]
36. In vivo technique for autofluorescent lipopigments. Delori FC; Dorey CK Methods Mol Biol; 1998; 108():229-43. PubMed ID: 9921533 [No Abstract] [Full Text] [Related]
37. Age-related macular degeneration and antioxidant status in the POLA study. POLA Study Group. Pathologies Oculaires Liées à l'Age. Delcourt C; Cristol JP; Tessier F; Léger CL; Descomps B; Papoz L Arch Ophthalmol; 1999 Oct; 117(10):1384-90. PubMed ID: 10532448 [TBL] [Abstract][Full Text] [Related]
38. Vitamin E and the age-related eye disease study supplementation for age-related macular degeneration. Chew EY; Clemons T Arch Ophthalmol; 2005 Mar; 123(3):395-6. PubMed ID: 15767485 [No Abstract] [Full Text] [Related]
39. Antioxidant vitamins in cataract prevention. Gerster H Z Ernahrungswiss; 1989 Mar; 28(1):56-75. PubMed ID: 2655316 [TBL] [Abstract][Full Text] [Related]
40. Effect of antioxidant supplementation in an elderly population. Srám RJ; Binková B; Topinka J; Kotĕsovec F; Fojtíková I; Hanel I; Klaschka J; Kocisóvá J; Prosek M; Machálek J Basic Life Sci; 1993; 61():459-77. PubMed ID: 8304954 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]